Zimmer Biomet announced that it signed a definitive agreement to acquire OrthoGrid Systems, a privately-held medical technology company focused on artificial intelligence-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents. The transaction is subject to customary closing conditions and is expected to be completed by the end of the fourth quarter of 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems, Inc.
- Zimmer Biomet Announces Second Quarter 2024 Financial Results
- ZBH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Osstem Implant in advanced talks to buy ZimVie, Bloomberg reports
- Zimmer Biomet price target lowered to $117 from $130 at Truist
Questions or Comments about the article? Write to editor@tipranks.com